Stryker Corporation (SYK) : Columbia Asset Management scooped up 300 additional shares in Stryker Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 8, 2016. The investment management firm now holds a total of 23,781 shares of Stryker Corporation which is valued at $2,747,419.Stryker Corporation makes up approximately 0.94% of Columbia Asset Management’s portfolio.
Other Hedge Funds, Including , Geneva Advisors boosted its stake in SYK in the latest quarter, The investment management firm added 2,155 additional shares and now holds a total of 20,339 shares of Stryker Corporation which is valued at $2,349,765. Stryker Corporation makes up approx 0.04% of Geneva Advisors’s portfolio.First National Bank Of Omaha reduced its stake in SYK by selling 134 shares or 1.39% in the most recent quarter. The Hedge Fund company now holds 9,500 shares of SYK which is valued at $1,162,420. Stryker Corporation makes up approx 0.09% of First National Bank Of Omaha’s portfolio.Professional Advisory Services Inc boosted its stake in SYK in the latest quarter, The investment management firm added 24,045 additional shares and now holds a total of 148,117 shares of Stryker Corporation which is valued at $18,013,990. Stryker Corporation makes up approx 4.01% of Professional Advisory Services Inc’s portfolio.Pacwest Financial Management Inc reduced its stake in SYK by selling 2,030 shares or 12.62% in the most recent quarter. The Hedge Fund company now holds 14,050 shares of SYK which is valued at $1,721,266. Stryker Corporation makes up approx 1.05% of Pacwest Financial Management Inc’s portfolio.
Stryker Corporation closed down -0.34 points or -0.29% at $115.23 with 5,68,638 shares getting traded on Monday. Post opening the session at $115.5, the shares hit an intraday low of $115.23 and an intraday high of $115.8 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.
Investors should note that on Jul 27, 2016, Stryker Corporation announced a cash dividend of $0.3800. The company’s management has announced Sep 28, 2016 as the ex-dividend date and fixed the record date on Sep 30, 2016. The payable date has been fixed on Oct 31, 2016.
Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Initiated by Guggenheim to “Buy” on Jun 9, 2016.
Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.